Matthieu Coutet

INSERM Transfert SA is a Venture Capital firm, a subsidiary of Institut National de la Sant? et de la Recherche M?dicale founded in 2000. INSERM Transfert SA is headquartered in Paris, France.

DNA Therapeutics SA operates as a clinical stage biopharmaceutical company. It focuses in the research and development of life-saving therapeutics for treatment-resistant cancers. The company was founded by Jian-Sheng Sun and Marie Dutreix in June 2006 and is headquartered in Evry, France.

Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France.

Bioaxial SAS develops and supplies live cell imaging instruments. It develops, manufactures and markets a super-resolution instrument for the life sciences and medical research communities. The firm's products include add-on module CODIM100 and Stand-Alone. The company was founded by Louis-Philippe Braitbart and Gabriel Sirat on February 24, 2010 and is headquartered in Paris, France.

Annapurna Therapeutics SAS operates as a gene therapy company. Its therapy restored cardiac function and reversed pathological heart enlargement in mice that had already progressed to heart failure. The company was founded by Pierre Bougneres, Hélène Puccio, Amber Salzman, Patrick Aubourg and Ronald G. Crystal and is headquartered in Paris, France.

Biovelocita Srl (Biovelocita) is a venture capital firm founded in 2015 by Silvano Spinelli, Gabriella Camboni and Sofinnova Partners. The firm is headquartered in Milan, Italy.

AdBio Partners SAS (AdBio Partners) is a venture capital firm founded in 2015. The firm is headquartered in Paris, France.

AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.